Patient: Page 23
-
PharmaVoice Team/PharmaVoice
The Change Agents
Lee Babiss, Ph.D. PPD Jeff Berkowitz Walgreen The Change agents (continued) Kathleen Castore Sanofi US Cathryn Clary, M.D. Ipsen Biopharmaceuticals Marianne Eisenmann Chandler Chicco Companies Leigh Householder GSW Worldwide Amir Kalali, M.D. Quintiles Dale Kummerle, Pharm.D...
By PharmaVoice Team • July 28, 2012 -
PharmaVoice Team/PharmaVoice
It's Time for Mobile: Do You Know Where Your Consumers Are?
By Robin Robinson There are several very solid reasons why the industry should be using mobile technology in its marketing efforts, but the one that stands out above all others is quite simple — mobile is where the consumers are. There are more smartphones than personal computers in the United St...
By PharmaVoice Team • May 29, 2012 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Postapproval Studies: More Critical and Challenging Than Ever
By Robin Robinson Phase IV data are in high demand by more stakeholders. As the need for postapproval data reaches a critical point, the industry explores the multiple options and struggles to determine which methods are best for collecting and analyzing important data. There are as many ways to ...
By PharmaVoice Team • May 29, 2012 -
PharmaVoice Team/PharmaVoice
Pharma 3.0
As the industry evolves to address a new ecosystem within the complex and global drug development and commercialization arena, companies will need to be open to using new technologies, thinking, and processes to make healthcare more sustainable, affordable, and accessible; improve the efficiency ...
By PharmaVoice Team • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Final Phase Goal: Maximize Uptake While Speeding to Launch
In every phase of drug development today, processes are more complex and more costly than ever and the drive to reduce time and expenditure is more critical. In today’s ever-changing marketplace, this holds true especially for the last stages of the process: registration, launch, and postlaunch. ...
By PharmaVoice Team • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Digital Patient-Centric Communications: Listen and Learn
Learning to listen and listening to learn are critical to a successful social networking marketing plan. While the buzzword in marketing these days is patient-centric, the industry still struggles with shifting its focus from products to consumers. Years of pushing product messaging out into the ...
By PharmaVoice Team • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Safety and Pharmacovigilance: A Moving Target
Robin Robinson The industry has always been under extreme scrutiny by regulators and the public, but the current business environment creates even more pressure on the pharmaceutical industry to stay compliant. Regulations and procedures are not only tightening but continually developing and c...
By PharmaVoice Team • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Hitting the Social Comfort Zone
Social Media Carolyn Gretton Pharmaceutical and biotechnology companies are shaking off their hesitance to employ social media tactics by forgoing potential marketing applications in favor of connecting with patients and providers in conversations that engage and inform. Most experts would likely...
By PharmaVoice Team • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Pharma 3.0 Next Steps
Robin Robinson Pharma Expands Disease Categories of 3.0 Efforts Between 2006 and 2009, 24% of Pharma 3.0 initiatives focused first on diabetes and metabolics. In 2010, oncology moved to the top with 15% of the year’s initiatives, and diabetes and metabolics tied for second with immunoscience/...
By PharmaVoice Team • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
The C-Suite: Corporate Strategies
New Ways Forward Experts agree the time has come to re-evaluate the overall working culture of the life-sciences industry, and they say innovation, new payer models, new stakeholders, and new outcomes are key considerations for future success. “Pharma will need to generate data that are timely, r...
By PharmaVoice Team • Nov. 11, 2011 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Marketing on a Two-Way Street
Social media is seen by many as today’s equivalent of meeting friends for a chat at the local diner or coffee shop, albeit with a much wider reach and somewhat longer life span message-wise. Joe Willis, VP, sales and marketing, SkinMedica, notes that social media is easy to access and instantly c...
By PharmaVoice Team • Sept. 27, 2011 -
PharmaVoice Team/PharmaVoice
The Marketers
New Media Mavens These tech-savvy marketers are energized by the possibilities present in the plethora of social media and other cutting-edge message-delivery tools. Alyson Connor • Driving Better Health Behaviors Curious. Passionate. Alyson Connor was a zookeeper. Alyson Connor can make the mos...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
The Clinical Specialists
Instinctive Innovators These experts in the clinical arena are evolving research and development practices, technologies, and development models to help bring new products to market faster, more cost-effectively, and with improved safety profiles. Mitchell Katz, Ph.D. • Leading by Example Suppor...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Scientific Pathfinders As R&D becomes more focused and specialized, these research experts are leading the way by breaking new ground. Julian Adams, Ph.D., is leading the charge in the war against cancer. Dr. Adams is best known for the discovery and development of Velcade (bortezomib), a pro...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
mHealth: Pharma's Next Blockbuster
The practice of mobile health, or mHealth as it is now known, has been around for decades. The first initiatives were designed to provide greater healthcare access to remote populations, mostly in developing countries. This trend continues and grows daily, providing many patients with a higher qu...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
The ABCs of Marketing — Advertising, Branding, and the Customer
The ABCs of MarketingWith the introduction of DTC advertising, health information became ubiquitous, reaching consumers where they live, work, and play. “Enter technology, the Internet, place-based media, mobile devices, social media, and information now are literally available at one’s fingertip...
By PharmaVoice Team • March 7, 2011 -
PharmaVoice Team/PharmaVoice
Digital Marketing: Dare to be Different
Research shows creativity is one of the most important components of a successful campaign, however, our experts say there are several other elements behind a campaign that need to be present to make the best of what digital media have to offer. Among them are matching the audience with the most ...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Achieving Global Launch Excellence
The details of what comprise a global launch vary depending upon who is doing the defining, but experts can agree that the launch environment is becoming more challenging. And with the value of the global pharmaceutical market expected to grow 5% to 7% in 2011, according to IMS Health, the incent...
By PharmaVoice Team • Dec. 27, 2010 -
PharmaVoice Team/PharmaVoice
Healthcare Reform and Comparative Effectiveness
We all know that R&D focus, pharmaceutical promotion, pricing, and reimbursement are all, or will be, critically affected by the biggest U.S. healthcare reform to occur in 40 years. The impact is going to be disruptive, but overall, experts says it will be a positive gain for the pharmaceutic...
By PharmaVoice Team • Nov. 10, 2010 -
PharmaVoice Team/PharmaVoice
The Sales Force of the Future
Of all the factors that will influence how sales reps perform their jobs tomorrow, experts outline training, specialty roles, and social media as the top three that will most influence the size, strategies, and success of sales forces in the future. Training is Crucial. As new skill sets become ...
By PharmaVoice Team • Nov. 10, 2010 -
PharmaVoice Team/PharmaVoice
Comparative Effectiveness: Real-World Evidence of Outcomes
Comparative effectiveness research is going to have a huge impact on every stakeholder in healthcare delivery. It requires a much broader view of the healthcare system so that information will exist about a patient’s outcome as he or she moves from diagnosis to treatment in the healthcare system....
By PharmaVoice Team • Aug. 27, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Lonnel COATS Eisai Names CEO for U.S. Subsidiary Eisai Inc., a U.S. subsidiary of Japan’s Eisai Co., has promoted Lonnel Coats to president and CEO, from president and chief operating officer. In addition, Mr. Coats has been appointed senior VP of Eisai Co.’s pharmaceuticals b...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Software as a Service: Gaining Traction
Many research firms have predicted that the worldwide economic recession is responsible for the global increase in the software-as-a-service (SaaS) market revenue. According to a recent Gartner report, SaaS is forecast to have a 17.7% compound annual growth rate through 2013 for the aggregate ent...
By PharmaVoice Team • March 23, 2010 -
PharmaVoice Team/PharmaVoice
Advertising In the Digital Age
The difficult economic environment of the past 18 months has forced many pharma companies to reexamine their shrinking advertising budgets and make best use of the resources that remain. Sandra Peterson, president of the Bayer Medical Care unit of Bayer HealthCare, notes that Bayer HealthCare rec...
By PharmaVoice Team • March 12, 2010 -
PharmaVoice Team/PharmaVoice
Opportunities in Oncology Development
Advances in cancer research, knowledge, treatment options, and awareness have increased tremendously in the past 25 years. Rates of new diagnoses and deaths from all cancers have declined significantly for men and women overall and for most racial and ethnic populations in the United States, acco...
By PharmaVoice Team • Jan. 28, 2010
Previous
